synopsis hasan 1.doc

Upload: palwasha-malik

Post on 07-Jul-2018

217 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/18/2019 SYNOPSIS Hasan 1.doc

    1/9

    SYNOPSIS for FCPS Part II

    To evaluate the outcome of Type C fractures of distal Radius

    managed with Volar LCP plates.

    By

    Dr. Sami RaaTR! "CPS ##

    $rthopaedic Surgery

    Supervisor 

    Prof. Shafiue %hmad Shafa&"CPS! %$ fellow '(ermany)

    *ead! Department of $rthopaedic Surgery

    Shai+h ,ayed "ederal Postgraduate -edical #nstitute!Lahore

    INTRODUCTION

  • 8/18/2019 SYNOPSIS Hasan 1.doc

    2/9

      Distal radius fractures represent approximately one-sixth of all fractures treated

    in emergency departments. The incidence of this injury appears to be both gender and age

    specific. There are three main peaks of fracture distribution: the first peak is in children

    ages 5 to 14 the second is in males under age 5! and the third peak is in females o"er the

    age of 4! years.

    Distal radius fractures in the elderly may represent an insufficiency fracture associated

    #ith all of the risk factors for osteoporosis.

     The majority of osteoporotic fractures occur as the result of a fall #hile the majority of

    injuries in the younger patients are secondary to motor "ehicle accidents and sports. $isk

    factors for distal radius fractures in the elderly ha"e been studied extensi"ely. Decreased

     bone mineral density female gender ethnicity heredity and early menopause ha"e all

     been sho#n to be risk factors.

    The optimal management of distal radius fractures has changed dramatically o"er the

     pre"ious t#o decades from almost uni"ersal use of cast immobili%ation to a "ariety of

    highly sophisticated operati"e inter"entions.OBJECTIVES

    The study is eing underta+en so as to determine the est evidence

    ased practice for the operative management of pro/imal femoral e/tra0articular 

    'su0trochenteric and pertrochenteric) fractures. The o1ective of the study is to

    compare the outcome of two fi/ation methods of e/tra0articular pro/imal femoral

    fractures y dynamic hip screw 'D*S) and pro/imal femoral nail 'P"2) in terms

    of functional outcome. $utcome of the surgery will e measured at 3! 45! and 46

    wee+s post0op in terms of functional outcome.

    &

  • 8/18/2019 SYNOPSIS Hasan 1.doc

    3/9

     "unctional outcome of the surgery which will e measured y -odified *arris

    *ip Score47! and will e graded as e/cellent! good! fair or poor. 8/cellent and

    good outcomes at 46 wee+s would indicate recovery of wal+ing aility.

    RATIONALE

      The study is eing conducted so as to determine the est practice for the

    treatment of our local population with the availale resources considering there

    are currently no reliale studies availale on the su1ect.

    MATERIALS AND METHODS

    ST9D: D8S#(2

     % randomied clinical trial

    PL%C8 $" ST9D:

    Department of $rthopaedics! Shai+h ,ayed *ospital! Lahore after approval y

    hospital ethical committee.

    D9R%T#$2 $" ST9D:

    #t will e completed in si/ months after the approval of the synopsis.

    S%-PL8 S#,8

    The sample sie was estimated y using ;< level of significance! 37< power of 

    test with e/pected outcome for wal+ing aility for P"2 and D*S =6.5.=

  • 8/18/2019 SYNOPSIS Hasan 1.doc

    4/9

     Pt will e prepared for surgery and operation theatre will e ready for oth

    procedures. Aust efore the surgery an envelope from two identical envelopes of 

    D*S and P"2 each will e randomly chosen and proceed with that surgery. 

    Incluson crt!ra

      4) %ge 5; 3; yrs of oth se/es.

      5) Type of fracture %ll e/tra0articular pro/imal femoral fractures 'pertrochenteric and

    sutrochenteric) will e included in the study

    E"cluson crt!ra

      4) Patient unwilling to participate in the study

    5) Patients with associated fractures of the lower lims! pelvis or the spine

    >) Patients with pre0e/isting condition of the hips e.g. rheumatoid arthritis!

    advanced osteoarthritis! infective arthritis! gouty arthritis! an+ylosing spondylitis etc

    assessed y history and pre0op /0rays..

    ?) Patients unfit for surgery on the asis of pre operative evaluation

    ;) %ge less than 5; and more than 3; will e e/cluded

    D%T% C$LL8CT#$2 PR$C8D9R8

     %ll the patients etween 5; 0 3; years of age with e/tra0articular pro/imal

    femoral fractures will e admitted in the orthopaedic department through

    emergency department or $PD. Demographic data and history will e ta+en

    relevant to the mode of in1ury and time since in1ury. %ll the patients will e

    e/amined and diagnosis will e confirmed with radiographic e/amination. S+in

    traction will e applied to the affected lim. Baseline investigations will e done

    and fitness for anesthesia and surgery will e otained preoperatively. #nformed

    written consent will e otained from all patients preoperatively for surgery

    4

  • 8/18/2019 SYNOPSIS Hasan 1.doc

    5/9

    including for research inclusion also. Pt will e prepared for surgery and

    operation theatre will e ready for oth procedures. Aust efore the surgery an

    envelope from two identical envelopes of D*S and P"2 each will e randomly

    chosen and allocated to that particular group. %ll the patients will e operated on

    ne/t regular list. %ll the patients will e operated on the fracture tale y the

    researcher. Standard anteroposterior and lateral radiographs will e done in the

    ward postoperatively. %ll patients will e given intravenous antiiotics

    preoperatively and for few days post operatively. Drains will e removed after ?3

    hours. Patient will e encouraged to moilie 4 5 days post0operatively. They

    will e advised to commence weight earing with support as tolerated after 5

    wee+s.

    The patients will e seen at two wee+s post0op for wound chec+ and stitch

    removal. "urther follow0up visits in outpatients department at 3! 45! and 46

    wee+s. Variales of -odified *arris *ip Score will e recorded on every follow

    up. Total score will e calculated and graded. "ailure of fi/ation will e reported

    as a discredit to the procedure.

    D%T% %2%L:S#S

     %ll the data will e entered and processed in SPSS 4;.7

     *arris *ip score will e presented y using mean E0 S.D for oth groups at 3!45 and 46 wee+s. Comparison for aove variales will e performed y using t0test or mannwhitney 90test depending on normality of date.(ender! functional outcome and complications will e processed y usingfre&uencies and percentages for oth groups.Comparison for these &ualitative variales will e performed y using Chi5 testand 0test for proportion.P0 Value F 7.7; will e considered statistically significant.

    5

  • 8/18/2019 SYNOPSIS Hasan 1.doc

    6/9

    PROFORMA

    Comparative study of outcome of e/tra0articular pro/imal femoral

    fractures treated with D*S and P"2

    Case 2o.................. *ospital no GGGGGGGG

    (roup...................... Date GGGGGGGGGG..

     '(roup % patients treated with D*S! (roup B patients treated with P"2)

    2ame.............................................................................%ge...........Se/................

     %ddress.................................................................................................................

    Profession.....................................................................

    -ode of in1ury

    Date of admission...................................Date of operation.................................

    Date of discharge...................................Time of procedureGGGGGGGGG.

    VARIABLES

    Mo#f!# Harrs H$ Scor!

    8ight wee+s Twelve wee+s Si/teen wee+s

    Total score(rade

    Functonal outco%! at &' (!!)s* poorEfairEgoodEe/cellent"inal wal+ing aility attained :E2

    (

  • 8/18/2019 SYNOPSIS Hasan 1.doc

    7/9

    Ann!"

    Grading Scale  F=7 Poor    =7 =H "air   37 3H (oodH7 477 8/cellent

    )

  • 8/18/2019 SYNOPSIS Hasan 1.doc

    8/9

    *

  • 8/18/2019 SYNOPSIS Hasan 1.doc

    9/9

    REFERENCES

    4. (ulerg B! Duppe *! 2ilsson B. #ncidence of *ip "ractures in -almo! Sweden'4H;74HH4). Bone! 4HH>I 4? 5> 0 H.

    5. Jannus P! $ar++ari A! Sievanen *! *einonen %! Vuori #! Aarvinen -.8pidemiology of hip fractures. Bone! 4HH6I 43 ;= 6>.

    >. Carmen %. Brauer! -D! -arcelo Coca0Perraillon! -%I David -. Cutler! %llisonB. Rosen. Incidence and -ortality of *ip "ractures in the 9nited States. A%-%!577H I >75'4?) 4;=>04;=H

    ?. 8vans 8-. Trochanteric fractures. % review of 447 cases treated y nail platefi/ation. A Bone A Surg! 4H;4I >>0B 4H5.

    ;. Dousa P! Bartonice+ A! Aehlic+a D! S+ala0Rosenaum A. $steosynthesis of trochanteric fracture using pro/imal femoral nail. %cta Chir $rthop TraumatolCech! 5775I 6H 55 >7.

    6.  Pa1arinen A! Lindahl A! -ichelsson $! Savolainen V! *irvensalo 8.Pertrochanteric femoral fractures treated with a dynamic hip screw or a pro/imalfemoral nail. % R%2D$-#S8D ST9D: C$-P%R#2( P$ST0$P8R%T#V8R8*%B#L#T%T#$2. A Bone A Surg! 577;I 3=0B! =6 0 34.

    =. Pavel+a T! -ate1+a A! Cerven+ova *. Complications of internal fi/ation y ashort pro/imal femoral nail. %cta Chir $rthop Traumatol Cech! 577;I =5 >??

    ;?.

    3. Lavini "! Reni0Brivio L!  %ulisa R! Cheruino "! Di Seglio PL! (alante 2!Leonardi K! -anca -. The treatment of stale and unstale pro/imal femoralfractures with a new trochanteric nail results of a multicentre study with theVeronail. ! 5773I >'4) 4; 0 55.

    H. Aiang LS! Shen L! Dai L:. #ntramedullary fi/ation of sutrochanteric fractureswith long pro/imal femoral nail or long gamma nail technical notes andpreliminary results. %nn %cad -ed Singapore! 577=I >6 354 6.

    47. *arris K*. Traumatic arthritis of the hip after dislocation and acetaular fractures treatment y mold arthroplasty. %n end0result study using a newmethod of result evaluation. A Bone Aoint Surg %m! 4H6HI ;4'?) =>= 0 ;;.

    +

    http://www.ncbi.nlm.nih.gov/pubmed?term=%22Lavini%20F%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Renzi-Brivio%20L%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Aulisa%20R%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Cherubino%20F%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Di%20Seglio%20PL%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Galante%20N%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Leonardi%20W%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Manca%20M%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/18427919http://www.ncbi.nlm.nih.gov/pubmed?term=%22Lavini%20F%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Renzi-Brivio%20L%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Aulisa%20R%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Cherubino%20F%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Di%20Seglio%20PL%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Galante%20N%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Leonardi%20W%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=%22Manca%20M%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/18427919